Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Update source : Investor.assemblybio.com save search
Assembly Biosciences Announces Additional Promising Data from Phase 1a Clinical Trial Evaluating Highly Potent Next-Generation Core Inhibitor Candidate ABI-4334 and Provides Pipeline Update
Published: 2023-04-18 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K
|
Health Technology
|
| O: -1.77%
H: 9.45%
C: -1.8%
abi-4334 candidate update pipeline trial
Assembly Biosciences Provides Update on its Core Inhibitor Pipeline, Reports Fourth Quarter and Year End 2022 Financial Results and Recent Highlights
Published: 2023-03-22 (Crawled : 21:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: -10.83%
year update financial results
Assembly Biosciences Announces Program Reprioritization and Organizational Update
Published: 2022-07-20 (Crawled : 21:00) - investor.assemblybio.com
ASMB | $13.64 2.33% 2.27% 11K
|
Health Technology
|
| O: 3.69%
H: 7.56%
C: 4.0%
program update
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.